Shaheen Majeed, President Worldwide, to speak about sustainability
Sabinsa will demonstrate a delicious next-generation solution for its #1 clinically studied brand of curcumin, Curcumin C3 Complex® as well as highlighting a number of GRAS-affirmed, science-based ingredients from the company’s substantial portfolio at Natural Products Expo West from March 5 – 7, 2020 at the Anaheim Convention Center, Anaheim, CA.
- Press Release
Sami-Sabinsa Group hosted a ground-breaking ceremony, on January 20, 2020, for a new Active Pharmaceutical Ingredients (API) manufacturing unit at Pharma SEZ Industrial Area, Hassan, Karnataka. The latest facility, with a planned investment of $30 Million USD, is part of the group’s strategy to expand existing ingredient growth, and focus on innovative new products. This will be the company’s eighth manufacturing facility.
The award was accepted by Ms. Asha Ramesh, Sabinsa USA’s CEO at an awards ceremony on November 14, 2019.
When the fastest growing 50 companies in New Jersey were announced by NJBIZ, a leading business journal in the state, Sabinsa was pleased to be identified as the 15th of the Fast 50.
Sabinsa has been granted U.S. patent US10166261 for a method of managing dementia and dementia-related sleep disorders presented as symptoms of major depressive disorder (MDD) in humans associated with Irritable Bowel Syndrome (IBS) by administering Bacillus coagulans MTCC 5856 (LactoSpore®) at a dose of 2 billion colony forming units per day. The patent also claims LactoSpore’s ability to reduce serum myeloperoxidase, an essential biochemical marker of MDD.
Reduction of TMAO Formation Found, Novel Findings for Heart Health
A new study collaboratively published by Sabinsa researchers and academic scientists from Taiwan and China, demonstrates that Sabinsa’s sustainably-sourced pterostilbene attenuates Trimethylamine-N-oxide (TMAO) formation and decreases vascular inflammation, confirming cardioprotective properties. The animal study findings were published online in the article Prevention of Vascular Inflammation by Pterostilbene via Trimethylamine-N-Oxide Reduction and Mechanism of Microbiota Regulation in Molecular Nutrition and Food Research (Volume 63, Issue 20).